ONCOCYTE :Liquid Biopsy | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ONCOCYTE :Liquid Biopsy

An SI Board Since January 2016

Posts	SubjectMarks	Bans	Symbol
29	5	0	OCX

Emcee: Savant	Type: Moderated

Introduction Market Data Compact

About OncoCyte Corporation

OncoCyte is primarily focused on the development and commercialization of novel, non-invasive liquid biopsy diagnostic tests for the early detection of cancer to improve health outcomes through early diagnoses, to reduce the cost of care through the avoidance of more costly diagnostic procedures, including invasive biopsy and cystoscopic procedures, and to improve the quality of life for cancer patients.

While current biopsy tests use invasive surgical procedures to provide tissue samples in order to determine if a tumor is benign or malignant, OncoCyte is developing a next generation of diagnostic tests that will be liquid biopsies using blood or urine samples. OncoCyte’s initial liquid biopsy tests under development are intended to be confirmatory diagnostics for detecting lung, bladder and breast cancer. OncoCyte’s diagnostic tests are being developed using proprietary sets of genetic and protein markers broadly expressed in numerous types of cancer.

For more information about OncoCyte, please visit www.OncoCyte.com.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
29	Bullish crossover in MACD and Stochastics. [graphic]	hollyhunter	-	9/12/2017
28	OCX..good news progress OncoCyte Receives CLIA Certification for its Cancer Diag	Savant	-	9/7/2017
27	FYI: Liquid biopsy startup RareCyte announces $30M round and new CEO to fuel ra	Glenn Petersen	1	8/29/2017
26	OncoCyte Confirms Launch Plans for Lung Cancer Diagnostic Test; Reports Progress	Savant	-	8/15/2017
25	OncoCyte Latest Lung Cancer Diagnostic Test Data Accepted for Slide Presentation	Savant	-	8/8/2017
24	OncoCyte Corp. (OCX) filed a Form 8K - Unregistered Sales of Equity - with the U	Savant	-	7/31/2017
23	OncoCyte Corporation Set to Join Russell 3000(R) Index ALAMEDA, Calif., June 12	Savant	-	6/12/2017
22	Presentation PDF globenewswire.com >>> investors.oncocyte.com	Savant	-	5/27/2017
21	OncoCyte Presents Positive Lung Cancer Blood Test Data at American Thoracic Soci	Savant	-	5/23/2017
20	lots of news, pps jump, stock halted, reopened..up 23.5%	Savant	-	5/23/2017
19	OncoCyte Reports Successful Results of Lung Cancer Diagnostic Test Study; Target	Savant	-	3/6/2017
18	OncoCyte Corporation to Present at Cowen and Company 37th Annual Health Care Con	Savant	-	3/1/2017
17	Looks like good entry point here. [graphic]	hollyhunter	-	2/27/2017
16	OncoCyte Corporation Reports Fourth Quarter and Full Year 2016 Financial Results	Savant	-	2/27/2017
15	OncoCyte Wins Buzz of BIO for the 2017 BIO CEO & Investor Conference ALAME	Savant	-	1/27/2017
14	Bullish crossover in MACD and Stochastic oscillator. [graphic]	hollyhunter	-	12/15/2016
13	SAN DIEGO, Dec. 7, 2016 /PRNewswire/ -- Organovo Holdings, Inc. (NASDAQ:ONVO) (&	Savant	-	12/7/2016
12	DEC 9th presentation... OncoCyte Corporation (NYSE MKT:OCX), a developer of nov	Savant	-	11/30/2016
11	OncoCyte and The Wistar Institute Present Lung Cancer Diagnostic Data at the CHE	Savant	-	10/17/2016
10	OncoCyte Corporation to Present at the BIO Investor Forum ALAMEDA, Calif., Oct.	Savant	-	10/14/2016
9	OncoCyte to Present Initial Data on its Breast Cancer Diagnostic Test at the Pre	Savant	-	9/8/2016
8	OncoCyte Corporation to Present at the Annual Gateway Conference ALAMEDA, Calif	Savant	-	9/7/2016
7	OncoCyte Corporation Announces the Closing of Two Private Placement Transactions	Savant	-	8/29/2016
6	OncoCyte Commences Analytical Verification Study for Lung Cancer Diagnostic Test	Savant	-	8/10/2016
5	OncoCyte and The Wistar Institute Announce Presentation of Lung Data at CHEST 20	Savant	-	7/27/2016

Go to reply# or date (mm/dd/yy):